| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000033868 |
| Receipt No. | R000038626 |
| Scientific Title | Effects of fermented rice extract intake on endurance exercise performance in human |
| Date of disclosure of the study information | 2018/08/23 |
| Last modified on | 2019/08/26 (Ver. 7) |
| Basic information | ||
| Public title | Effects of fermented rice extract intake on endurance exercise performance in human | |
| Acronym | Effects of fermented rice extract intake on endurance exercise performance in human | |
| Scientific Title | Effects of fermented rice extract intake on endurance exercise performance in human | |
| Scientific Title:Acronym | Effects of fermented rice extract intake on endurance exercise performance in human | |
| Region |
|
|
| Condition | |||
| Condition | Healthy | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The aim of this study is to investigate the effect of constant fermented rice extract intake on endurance exercise performance (Aerobic work capacity) in trained male college athletes. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Maximum oxygen consumption (estimate value) and anaerobic threshold during increment exercise test, and changes in blood lactate concentration and expiration gas parameters during constant exercise test.
|
| Key secondary outcomes | 1) Changes in blood glucose concentration during constant exercise test.
2) Changes in subjective fatigue parameters (VAS, POMS, stroop test, etc) 3) Changes in blood oxidative stress marker 4) Questionnaire about fatigue |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Subjects drink the fermented rice extract for 3 weeks (100 mL/day). | |
| Interventions/Control_2 | Subjects drink placebo for 3 weeks (100 mL/day). | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1) College students who belong to sports clubs.
2) Over 19-year-old 3) Male 4) Subjects who give consent in writing based on their own free will to attend this study after enough informed consent. |
|||
| Key exclusion criteria | 1) Subjects with a history of cardiovascular disease.
2) Subjects who get diseases and injured with inability to exercise during the experimental period. 3) Subjects who take drug, food, and equipment that affect the results of this study. 4) Subjects who judged inappropriate by the principal investigator or doctor. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kanazawa University | ||||||
| Division name | Faculty of Human Sciences | ||||||
| Zip code | 920-1192 | ||||||
| Address | Kakuma-machi, Kanazawa City, Ishikawa, Japan | ||||||
| TEL | 076-264-5568 | ||||||
| masudak@staff.kanazawa-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kanazawa University | ||||||
| Division name | Faculty of Human Sciences | ||||||
| Zip code | 920-1192 | ||||||
| Address | Kakuma-machi, Kanazawa City, Ishikawa, Japan | ||||||
| TEL | 076-264-5568 | ||||||
| Homepage URL | |||||||
| masudak@staff.kanazawa-u.ac.jp | |||||||
| Sponsor | |
| Institute | Kanazawa University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ishikawa Sunrise Industries Creation Organization |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institute of Human and Social Sciences Ethics Committee, Kanazawa University |
| Address | Kakuma-machi, Kanazawa City, Ishikawa, Japan |
| Tel | 076-264-5450 |
| n-somu@adm.kanazawa-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 19 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000038626 |